Condition
Scar, Hypertrophic
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Recruiting2
Enrolling By Invitation1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05461157Not ApplicableEnrolling By Invitation
Preoperative Silicone Ointment and Wound Healing
NCT05984628Not ApplicableRecruiting
Umbilical Cord Stem Cells for Skin Grafts in Donor Site Wounds
NCT06729840Phase 3RecruitingPrimary
Intralesional Treatment of Keloids
Showing all 3 trials